Christine Rettew Fisher

Title: Christine Rettew Fisher: Innovator in Rabies Vaccine Development

Introduction

Christine Rettew Fisher, based in Philadelphia, PA, is a notable inventor known for her significant contributions to the field of vaccine development. With one patent to her name, she has played an essential role in advancing public health through her innovative research.

Latest Patents

Christine Rettew Fisher's patent focuses on "Compositions and administration of chimeric glycoprotein lyssavirus vaccines for coverage against rabies." The patent details the development of chimeric glycoproteins that comprise various defined domains, such as the clip region, core region, flap region, and transmembrane and cytoplasmic domains. These domains are essential for the effective functioning of the vaccine vector, enhancing its efficacy against rabies.

Career Highlights

Christine has made considerable strides in her career through her work at reputable institutions like Thomas Jefferson University and the Icahn School of Medicine at Mount Sinai. Her role in these organizations has allowed her to contribute valuable research and innovation in the medical field, specially focused on virology and vaccine development.

Collaborations

Throughout her career, Christine has collaborated with notable colleagues, including Matthias Johannes Schnell and Christoph Wirblich. These partnerships have enriched her research endeavors, leading to breakthroughs in the understanding and prevention of rabies.

Conclusion

Christine Rettew Fisher’s contributions to the field of vaccine research illustrate her dedication to public health and innovation. Her patent on chimeric glycoprotein vaccines marks a significant advancement in the fight against rabies, showcasing her impactful work as an inventor.